AR061606A1 - Formas solidas de rimonabant y procesos para su preparacion - Google Patents
Formas solidas de rimonabant y procesos para su preparacionInfo
- Publication number
- AR061606A1 AR061606A1 ARP070102763A ARP070102763A AR061606A1 AR 061606 A1 AR061606 A1 AR 061606A1 AR P070102763 A ARP070102763 A AR P070102763A AR P070102763 A ARP070102763 A AR P070102763A AR 061606 A1 AR061606 A1 AR 061606A1
- Authority
- AR
- Argentina
- Prior art keywords
- rimonabant
- preparation
- solid forms
- processes
- 2theta
- Prior art date
Links
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003015 rimonabant Drugs 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 208000008589 Obesity Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente se relaciona con formas solidas de rimonabant y rimonabant amorfo y con los procesos de síntesis para la preparacion de los mismos. Tratamiento de la obesidad. Reivindicacion 1: Solvato de etanol de rimonabant, caracterizado porque presenta un patron de difraccion de rayos X de polvo (2theta)(+- 0, 2°) con picos principales a 6, 7, 8, 4, 10, 1, 12, 1, 13, 5, 14, 4, 16, 7, 18, 2, 19, 3, 20, 9 y 21, 8° aproximadamente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81556406P | 2006-06-22 | 2006-06-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR061606A1 true AR061606A1 (es) | 2008-09-10 |
Family
ID=39230601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070102763A AR061606A1 (es) | 2006-06-22 | 2007-06-22 | Formas solidas de rimonabant y procesos para su preparacion |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR061606A1 (es) |
| WO (1) | WO2008038143A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008026219A2 (en) * | 2006-09-01 | 2008-03-06 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
| WO2008064615A2 (en) * | 2006-12-01 | 2008-06-05 | Zentiva, A.S. | Crystalline and amorphous forms of rimonabant and processes for obtaining them |
| US20080182877A1 (en) * | 2007-01-05 | 2008-07-31 | Westheim Raymond J H | Rimonabant forms and methods of making the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713225B1 (fr) * | 1993-12-02 | 1996-03-01 | Sanofi Sa | N-pipéridino-3-pyrazolecarboxamide substitué. |
| FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
| FR2831883B1 (fr) * | 2001-11-08 | 2004-07-23 | Sanofi Synthelabo | Forme polymorphe du rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant |
| EP1816125A1 (en) * | 2006-02-02 | 2007-08-08 | Ranbaxy Laboratories, Ltd. | Novel crystalline forms of an antagonist of CB1 cannabinoid receptor and preparation method thereof |
| WO2008026219A2 (en) * | 2006-09-01 | 2008-03-06 | Hetero Drugs Limited | Novel polymorphs of rimonabant |
| EP1953144A1 (en) * | 2007-01-30 | 2008-08-06 | Sandoz AG | Novel polymorphic forms of N-piperidino-5-(4-chlorophenyl)-1-(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
-
2007
- 2007-06-22 WO PCT/IB2007/003678 patent/WO2008038143A2/en not_active Ceased
- 2007-06-22 AR ARP070102763A patent/AR061606A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008038143A3 (en) | 2009-02-19 |
| WO2008038143A2 (en) | 2008-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063347A1 (es) | Formas cristalinas de docetaxel y proceso para su preparacion | |
| NZ594746A (en) | Inhibitors of iap | |
| TW200709480A (en) | Shaping a phase change layer in a phase change memory cell | |
| IL192944A0 (en) | THE USE OF AN ANTI-EpCAM ANTIBODY FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION | |
| DK2227243T3 (da) | Farmaceutisk sammensætning til behandling af obesitet relaterede sygdomme, omfattende et insulinotropisk peptidkonjugat | |
| PA8645301A1 (es) | Anticuerpo anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina | |
| CL2008000831A1 (es) | Procesos para extraer exceso de proteina soluble e impurezas a partir de lisados celulares de serotipos de streptococcus pneumoniae utilizados en la produccion de polisacaridos neumococales. | |
| AR048527A1 (es) | Variedades cristalinas de acetato de bazedoxifeno | |
| AR077203A1 (es) | Forma polimorfica d del acetato de bazedoxifeno, composiciones farmaceuticas que la contienen metodo para prepararla y uso del mismo para tratar enfermedades mediadas por moduladores selectivos de receptores estrogenicos (serms) | |
| EP2046359A4 (en) | ANTI-INFLAMMATION OF THE SOLVENT FILM | |
| CO6280489A2 (es) | (r)-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida cristalina | |
| IL200388A (en) | Antibody, antibody hybridoma, antibody-containing conjugate, antibody-containing drug and / or conjugate and their uses | |
| NZ599480A (en) | Solid forms comprising (-)-o-desmethylvenlafaxine and uses thereof | |
| ZA200807196B (en) | Processes for the convergent synthesis of calicheamicin derivatives | |
| AP2400A (en) | New process for the synthesis of strontium ranelate and its hydrates. | |
| PT1893224T (pt) | Utilização de uma membrana de célula vegetal para o tratamento da obesidade | |
| AR061606A1 (es) | Formas solidas de rimonabant y procesos para su preparacion | |
| AR113893A1 (es) | Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción | |
| ZA200709177B (en) | Combined multi-layered water soluble film and process for producing the same | |
| NI200700175A (es) | Procesos para la preparación de alcoholes de aminoetoxibencilo | |
| EA200900936A1 (ru) | Аморфные и кристаллические формы ривастигмина гидротартрата | |
| WO2006085118A3 (en) | Dihydroimidazothiazole derivatives | |
| GB0403808D0 (en) | Films for use as dosage forms | |
| GEP20094854B (en) | Compounds for treating diseases of impaired gastric motility | |
| AR066133A1 (es) | Formas cristalinas de clorhidrato de topotecan y procesos para prepararlas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |